APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Neurorehabilitation Biofeedback Therapy Device

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Neurorehabilitation Biofeedback Therapy Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

24 December 2025196 pages

Choose your research edition.

Industry ResearchNeurorehabilitation Biofeedback Therapy Device Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Neurorehabilitation Biofeedback Therapy Device Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Neurorehabilitation Biofeedback Therapy Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Neurorehabilitation Biofeedback Therapy Device Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Neurorehabilitation Biofeedback Therapy Device Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Neurorehabilitation Biofeedback Therapy Device market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Neurorehabilitation Biofeedback Therapy Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Neurorehabilitation Biofeedback Therapy Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Neurorehabilitation Biofeedback Therapy Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Neurorehabilitation Biofeedback Therapy Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Neurorehabilitation Biofeedback Therapy Device include Abbott, ARKRAY, Ascensia, B. Braun, BIONIME, GMMC Group, LIANFA, Lifescan and Lobeck Medical AG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Neurorehabilitation Biofeedback Therapy Device market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Neurorehabilitation Biofeedback Therapy Device and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Neurorehabilitation Biofeedback Therapy Device sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Neurorehabilitation Biofeedback Therapy Device market size, projected growth trends, production technologies, key applications, and end-use industries.

Neurorehabilitation Biofeedback Therapy Device Segment by Company

Abbott

ARKRAY

Ascensia

B. Braun

BIONIME

GMMC Group

LIANFA

Lifescan

Lobeck Medical AG

Sinocare

TERUMO

Roche

Neurorehabilitation Biofeedback Therapy Device Segment by Type

Conventional

Intelligent

Neurorehabilitation Biofeedback Therapy Device Segment by Application

Hospital

Clinic

Others

Neurorehabilitation Biofeedback Therapy Device Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neurorehabilitation Biofeedback Therapy Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Neurorehabilitation Biofeedback Therapy Device and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neurorehabilitation Biofeedback Therapy Device.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Neurorehabilitation Biofeedback Therapy Device market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Neurorehabilitation Biofeedback Therapy Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Neurorehabilitation Biofeedback Therapy Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Neurorehabilitation Biofeedback Therapy Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Neurorehabilitation Biofeedback Therapy Device Industry Trends Table 2. Neurorehabilitation Biofeedback Therapy Device Industry Drivers Table 3. Neurorehabilitation Biofeedback Therapy Device Industry Opportunities and Challenges Table 4. Neurorehabilitation Biofeedback Therapy Device Industry Restraints Table 5. Global Neurorehabilitation Biofeedback Therapy Device Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Neurorehabilitation Biofeedback Therapy Device Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Neurorehabilitation Biofeedback Therapy Device Sales by Manufacturers (Units) & (2021-2026) Table 8. Global Neurorehabilitation Biofeedback Therapy Device Sales Market Share by Manufacturers Table 9. Global Neurorehabilitation Biofeedback Therapy Device Average Sales Price (K US$/Unit) of Manufacturers (2021-2026) Table 10. Global Neurorehabilitation Biofeedback Therapy Device Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Neurorehabilitation Biofeedback Therapy Device Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Neurorehabilitation Biofeedback Therapy Device Manufacturers, Product Type & Application Table 13. Global Neurorehabilitation Biofeedback Therapy Device Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Neurorehabilitation Biofeedback Therapy Device by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Conventional Table 17. Major Manufacturers of Intelligent Table 18. Global Neurorehabilitation Biofeedback Therapy Device Sales by Type 2021 VS 2025 VS 2032 (Units) Table 19. Global Neurorehabilitation Biofeedback Therapy Device Sales by Type (2021-2026) & (Units) Table 20. Global Neurorehabilitation Biofeedback Therapy Device Sales by Type (2027-2032) & (Units) Table 21. Global Neurorehabilitation Biofeedback Therapy Device Sales Market Share by Type (2021-2026) Table 22. Global Neurorehabilitation Biofeedback Therapy Device Sales Market Share by Type (2027-2032) Table 23. Global Neurorehabilitation Biofeedback Therapy Device Revenue by Type 2021 VS 2025 VS 2032 (Units) Table 24. Global Neurorehabilitation Biofeedback Therapy Device Revenue by Type (2021-2026) & (Units) Table 25. Global Neurorehabilitation Biofeedback Therapy Device Revenue by Type (2027-2032) & (Units) Table 26. Global Neurorehabilitation Biofeedback Therapy Device Revenue Market Share by Type (2021-2026) Table 27. Global Neurorehabilitation Biofeedback Therapy Device Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Clinic Table 30. Major Manufacturers of Others Table 31. Global Neurorehabilitation Biofeedback Therapy Device Sales by Application 2021 VS 2025 VS 2032 (Units) Table 32. Global Neurorehabilitation Biofeedback Therapy Device Sales by Application (2021-2026) & (Units) Table 33. Global Neurorehabilitation Biofeedback Therapy Device Sales by Application (2027-2032) & (Units) Table 34. Global Neurorehabilitation Biofeedback Therapy Device Sales Market Share by Application (2021-2026) Table 35. Global Neurorehabilitation Biofeedback Therapy Device Sales Market Share by Application (2027-2032) Table 36. Global Neurorehabilitation Biofeedback Therapy Device Revenue by Application 2021 VS 2025 VS 2032 (Units) Table 37. Global Neurorehabilitation Biofeedback Therapy Device Revenue by Application (2021-2026) & (Units) Table 38. Global Neurorehabilitation Biofeedback Therapy Device Revenue by Application (2027-2032) & (Units) Table 39. Global Neurorehabilitation Biofeedback Therapy Device Revenue Market Share by Application (2021-2026) Table 40. Global Neurorehabilitation Biofeedback Therapy Device Revenue Market Share by Application (2027-2032) Table 41. Global Neurorehabilitation Biofeedback Therapy Device Sales by Region: 2021 VS 2025 VS 2032 (Units) Table 42. Global Neurorehabilitation Biofeedback Therapy Device Sales by Region (2021-2026) & (Units) Table 43. Global Neurorehabilitation Biofeedback Therapy Device Sales Market Share by Region (2021-2026) Table 44. Global Neurorehabilitation Biofeedback Therapy Device Sales Forecasted by Region (2027-2032) & (Units) Table 45. Global Neurorehabilitation Biofeedback Therapy Device Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Neurorehabilitation Biofeedback Therapy Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 47. North America Neurorehabilitation Biofeedback Therapy Device Sales by Country (2021-2026) & (Units) Table 48. North America Neurorehabilitation Biofeedback Therapy Device Sales by Country (2027-2032) & (Units) Table 49. Europe Neurorehabilitation Biofeedback Therapy Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 50. Europe Neurorehabilitation Biofeedback Therapy Device Sales by Country (2021-2026) & (Units) Table 51. Europe Neurorehabilitation Biofeedback Therapy Device Sales by Country (2027-2032) & (Units) Table 52. Asia Pacific Neurorehabilitation Biofeedback Therapy Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 53. Asia Pacific Neurorehabilitation Biofeedback Therapy Device Sales by Country (2021-2026) & (Units) Table 54. Asia Pacific Neurorehabilitation Biofeedback Therapy Device Sales by Country (2027-2032) & (Units) Table 55. South America, Middle East and Africa Neurorehabilitation Biofeedback Therapy Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 56. South America, Middle East and Africa Neurorehabilitation Biofeedback Therapy Device Sales by Country (2021-2026) & (Units) Table 57. South America, Middle East and Africa Neurorehabilitation Biofeedback Therapy Device Sales by Country (2027-2032) & (Units) Table 58. Global Neurorehabilitation Biofeedback Therapy Device Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Neurorehabilitation Biofeedback Therapy Device Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Neurorehabilitation Biofeedback Therapy Device Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Neurorehabilitation Biofeedback Therapy Device Revenue Market Share by Region (2021-2026) Table 62. Global Neurorehabilitation Biofeedback Therapy Device Revenue Market Share by Region (2027-2032) Table 63. Abbott Company Information Table 64. Abbott Business Overview Table 65. Abbott Neurorehabilitation Biofeedback Therapy Device Sales (Units), Price (K US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Abbott Neurorehabilitation Biofeedback Therapy Device Product Portfolio Table 67. Abbott Recent Development Table 68. ARKRAY Company Information Table 69. ARKRAY Business Overview Table 70. ARKRAY Neurorehabilitation Biofeedback Therapy Device Sales (Units), Price (K US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. ARKRAY Neurorehabilitation Biofeedback Therapy Device Product Portfolio Table 72. ARKRAY Recent Development Table 73. Ascensia Company Information Table 74. Ascensia Business Overview Table 75. Ascensia Neurorehabilitation Biofeedback Therapy Device Sales (Units), Price (K US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Ascensia Neurorehabilitation Biofeedback Therapy Device Product Portfolio Table 77. Ascensia Recent Development Table 78. B. Braun Company Information Table 79. B. Braun Business Overview Table 80. B. Braun Neurorehabilitation Biofeedback Therapy Device Sales (Units), Price (K US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. B. Braun Neurorehabilitation Biofeedback Therapy Device Product Portfolio Table 82. B. Braun Recent Development Table 83. BIONIME Company Information Table 84. BIONIME Business Overview Table 85. BIONIME Neurorehabilitation Biofeedback Therapy Device Sales (Units), Price (K US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. BIONIME Neurorehabilitation Biofeedback Therapy Device Product Portfolio Table 87. BIONIME Recent Development Table 88. GMMC Group Company Information Table 89. GMMC Group Business Overview Table 90. GMMC Group Neurorehabilitation Biofeedback Therapy Device Sales (Units), Price (K US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. GMMC Group Neurorehabilitation Biofeedback Therapy Device Product Portfolio Table 92. GMMC Group Recent Development Table 93. LIANFA Company Information Table 94. LIANFA Business Overview Table 95. LIANFA Neurorehabilitation Biofeedback Therapy Device Sales (Units), Price (K US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. LIANFA Neurorehabilitation Biofeedback Therapy Device Product Portfolio Table 97. LIANFA Recent Development Table 98. Lifescan Company Information Table 99. Lifescan Business Overview Table 100. Lifescan Neurorehabilitation Biofeedback Therapy Device Sales (Units), Price (K US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Lifescan Neurorehabilitation Biofeedback Therapy Device Product Portfolio Table 102. Lifescan Recent Development Table 103. Lobeck Medical AG Company Information Table 104. Lobeck Medical AG Business Overview Table 105. Lobeck Medical AG Neurorehabilitation Biofeedback Therapy Device Sales (Units), Price (K US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Lobeck Medical AG Neurorehabilitation Biofeedback Therapy Device Product Portfolio Table 107. Lobeck Medical AG Recent Development Table 108. Sinocare Company Information Table 109. Sinocare Business Overview Table 110. Sinocare Neurorehabilitation Biofeedback Therapy Device Sales (Units), Price (K US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Sinocare Neurorehabilitation Biofeedback Therapy Device Product Portfolio Table 112. Sinocare Recent Development Table 113. TERUMO Company Information Table 114. TERUMO Business Overview Table 115. TERUMO Neurorehabilitation Biofeedback Therapy Device Sales (Units), Price (K US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. TERUMO Neurorehabilitation Biofeedback Therapy Device Product Portfolio Table 117. TERUMO Recent Development Table 118. Roche Company Information Table 119. Roche Business Overview Table 120. Roche Neurorehabilitation Biofeedback Therapy Device Sales (Units), Price (K US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Roche Neurorehabilitation Biofeedback Therapy Device Product Portfolio Table 122. Roche Recent Development Table 123. Key Raw Materials Table 124. Raw Materials Key Suppliers Table 125. Neurorehabilitation Biofeedback Therapy Device Distributors List Table 126. Neurorehabilitation Biofeedback Therapy Device Customers List Table 127. Research Programs/Design for This Report Table 128. Authors List of This Report Table 129. Secondary Sources Table 130. Primary Sources List of Figures Figure 1. Neurorehabilitation Biofeedback Therapy Device Product Image Figure 2. Global Neurorehabilitation Biofeedback Therapy Device Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Neurorehabilitation Biofeedback Therapy Device Market Size (2021-2032) & (US$ Million) Figure 4. Global Neurorehabilitation Biofeedback Therapy Device Sales (2021-2032) & (Units) Figure 5. Global Neurorehabilitation Biofeedback Therapy Device Average Price (K US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Neurorehabilitation Biofeedback Therapy Device Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Conventional Image Figure 9. Intelligent Image Figure 10. Global Neurorehabilitation Biofeedback Therapy Device Sales by Type (2021 VS 2025 VS 2032) & (Units) Figure 11. Global Neurorehabilitation Biofeedback Therapy Device Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Neurorehabilitation Biofeedback Therapy Device Sales Market Share by Type (2021-2032) Figure 13. Global Neurorehabilitation Biofeedback Therapy Device Revenue by Type (2021 VS 2025 VS 2032) & (Units) Figure 14. Global Neurorehabilitation Biofeedback Therapy Device Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Neurorehabilitation Biofeedback Therapy Device Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinic Image Figure 18. Others Image Figure 19. Global Neurorehabilitation Biofeedback Therapy Device Sales by Application (2021 VS 2025 VS 2032) & (Units) Figure 20. Global Neurorehabilitation Biofeedback Therapy Device Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Neurorehabilitation Biofeedback Therapy Device Sales Market Share by Application (2021-2032) Figure 22. Global Neurorehabilitation Biofeedback Therapy Device Revenue by Application (2021 VS 2025 VS 2032) & (Units) Figure 23. Global Neurorehabilitation Biofeedback Therapy Device Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Neurorehabilitation Biofeedback Therapy Device Revenue Market Share by Application (2021-2032) Figure 25. North America Neurorehabilitation Biofeedback Therapy Device Sales and Growth Rate (2021-2032) & (Units) Figure 26. North America Neurorehabilitation Biofeedback Therapy Device Sales Market Share by Country (2021-2032) Figure 27. U.S. Neurorehabilitation Biofeedback Therapy Device Sales and Growth Rate (2021-2032) & (Units) Figure 28. Canada Neurorehabilitation Biofeedback Therapy Device Sales and Growth Rate (2021-2032) & (Units) Figure 29. Mexico Neurorehabilitation Biofeedback Therapy Device Sales and Growth Rate (2021-2032) & (Units) Figure 30. Europe Neurorehabilitation Biofeedback Therapy Device Sales and Growth Rate (2021-2032) & (Units) Figure 31. Europe Neurorehabilitation Biofeedback Therapy Device Sales Market Share by Country (2021-2032) Figure 32. Germany Neurorehabilitation Biofeedback Therapy Device Sales and Growth Rate (2021-2032) & (Units) Figure 33. France Neurorehabilitation Biofeedback Therapy Device Sales and Growth Rate (2021-2032) & (Units) Figure 34. U.K. Neurorehabilitation Biofeedback Therapy Device Sales and Growth Rate (2021-2032) & (Units) Figure 35. Italy Neurorehabilitation Biofeedback Therapy Device Sales and Growth Rate (2021-2032) & (Units) Figure 36. Netherlands Neurorehabilitation Biofeedback Therapy Device Sales and Growth Rate (2021-2032) & (Units) Figure 37. Asia Pacific Neurorehabilitation Biofeedback Therapy Device Sales and Growth Rate (2021-2032) & (Units) Figure 38. Asia Pacific Neurorehabilitation Biofeedback Therapy Device Sales Market Share by Country (2021-2032) Figure 39. China Neurorehabilitation Biofeedback Therapy Device Sales and Growth Rate (2021-2032) & (Units) Figure 40. Japan Neurorehabilitation Biofeedback Therapy Device Sales and Growth Rate (2021-2032) & (Units) Figure 41. South Korea Neurorehabilitation Biofeedback Therapy Device Sales and Growth Rate (2021-2032) & (Units) Figure 42. Southeast Asia Neurorehabilitation Biofeedback Therapy Device Sales and Growth Rate (2021-2032) & (Units) Figure 43. India Neurorehabilitation Biofeedback Therapy Device Sales and Growth Rate (2021-2032) & (Units) Figure 44. Australia Neurorehabilitation Biofeedback Therapy Device Sales and Growth Rate (2021-2032) & (Units) Figure 45. South America, Middle East and Africa Neurorehabilitation Biofeedback Therapy Device Sales and Growth Rate (2021-2032) & (Units) Figure 46. South America, Middle East and Africa Neurorehabilitation Biofeedback Therapy Device Sales Market Share by Country (2021-2032) Figure 47. Brazil Neurorehabilitation Biofeedback Therapy Device Sales and Growth Rate (2021-2032) & (Units) Figure 48. South Africa Neurorehabilitation Biofeedback Therapy Device Sales and Growth Rate (2021-2032) & (Units) Figure 49. Saudi Arabia Neurorehabilitation Biofeedback Therapy Device Sales and Growth Rate (2021-2032) & (Units) Figure 50. Turkey Neurorehabilitation Biofeedback Therapy Device Sales and Growth Rate (2021-2032) & (Units) Figure 51. Argentina Neurorehabilitation Biofeedback Therapy Device Sales and Growth Rate (2021-2032) & (Units) Figure 52. UAE Neurorehabilitation Biofeedback Therapy Device Sales and Growth Rate (2021-2032) & (Units) Figure 53. Egypt Neurorehabilitation Biofeedback Therapy Device Sales and Growth Rate (2021-2032) & (Units) Figure 54. Chile Neurorehabilitation Biofeedback Therapy Device Sales and Growth Rate (2021-2032) & (Units) Figure 55. Global Neurorehabilitation Biofeedback Therapy Device Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Neurorehabilitation Biofeedback Therapy Device Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Neurorehabilitation Biofeedback Therapy Device Revenue (2021-2032) & (US$ Million) Figure 58. North America Neurorehabilitation Biofeedback Therapy Device Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Neurorehabilitation Biofeedback Therapy Device Revenue (2021-2032) & (US$ Million) Figure 60. Europe Neurorehabilitation Biofeedback Therapy Device Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Neurorehabilitation Biofeedback Therapy Device Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Neurorehabilitation Biofeedback Therapy Device Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Neurorehabilitation Biofeedback Therapy Device Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Neurorehabilitation Biofeedback Therapy Device Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Neurorehabilitation Biofeedback Therapy Device Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Neurorehabilitation Biofeedback Therapy Device Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Conventional
  • Intelligent
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Abbott
  • ARKRAY
  • Ascensia
  • B. Braun
  • BIONIME
  • GMMC Group
  • LIANFA
  • Lifescan
  • Lobeck Medical AG
  • Sinocare
  • TERUMO
  • Roche

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Neurorehabilitation Biofeedback Therapy Device Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Neurorehabilitation Biofeedback Therapy Device Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Neurorehabilitation Biofeedback Therapy Device Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Neurorehabilitation Biofeedback Therapy Device Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Neurorehabilitation Biofeedback Therapy Device Market Dynamics
  1. 2.1 Neurorehabilitation Biofeedback Therapy Device Industry Trends
  2. 2.2 Neurorehabilitation Biofeedback Therapy Device Industry Drivers
  3. 2.3 Neurorehabilitation Biofeedback Therapy Device Industry Opportunities and Challenges
  4. 2.4 Neurorehabilitation Biofeedback Therapy Device Industry Restraints
3 Neurorehabilitation Biofeedback Therapy Device Market by Manufacturers
  1. 3.1 Global Neurorehabilitation Biofeedback Therapy Device Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Neurorehabilitation Biofeedback Therapy Device Sales by Manufacturers (2021-2026)
  3. 3.3 Global Neurorehabilitation Biofeedback Therapy Device Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Neurorehabilitation Biofeedback Therapy Device Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Neurorehabilitation Biofeedback Therapy Device Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Neurorehabilitation Biofeedback Therapy Device Manufacturers, Product Type & Application
  7. 3.7 Global Neurorehabilitation Biofeedback Therapy Device Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Neurorehabilitation Biofeedback Therapy Device Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Neurorehabilitation Biofeedback Therapy Device Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Neurorehabilitation Biofeedback Therapy Device Tier 1, Tier 2, and Tier 3
4 Neurorehabilitation Biofeedback Therapy Device Market by Type
  1. 4.1 Neurorehabilitation Biofeedback Therapy Device Type Introduction
  2. 4.1.1 Conventional
  3. 4.1.2 Intelligent
  4. 4.2 Global Neurorehabilitation Biofeedback Therapy Device Sales by Type
  5. 4.2.1 Global Neurorehabilitation Biofeedback Therapy Device Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Neurorehabilitation Biofeedback Therapy Device Sales by Type (2021-2032)
  7. 4.2.3 Global Neurorehabilitation Biofeedback Therapy Device Sales Market Share by Type (2021-2032)
  8. 4.3 Global Neurorehabilitation Biofeedback Therapy Device Revenue by Type
  9. 4.3.1 Global Neurorehabilitation Biofeedback Therapy Device Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Neurorehabilitation Biofeedback Therapy Device Revenue by Type (2021-2032)
  11. 4.3.3 Global Neurorehabilitation Biofeedback Therapy Device Revenue Market Share by Type (2021-2032)
5 Neurorehabilitation Biofeedback Therapy Device Market by Application
  1. 5.1 Neurorehabilitation Biofeedback Therapy Device Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Neurorehabilitation Biofeedback Therapy Device Sales by Application
  6. 5.2.1 Global Neurorehabilitation Biofeedback Therapy Device Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Neurorehabilitation Biofeedback Therapy Device Sales by Application (2021-2032)
  8. 5.2.3 Global Neurorehabilitation Biofeedback Therapy Device Sales Market Share by Application (2021-2032)
  9. 5.3 Global Neurorehabilitation Biofeedback Therapy Device Revenue by Application
  10. 5.3.1 Global Neurorehabilitation Biofeedback Therapy Device Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Neurorehabilitation Biofeedback Therapy Device Revenue by Application (2021-2032)
  12. 5.3.3 Global Neurorehabilitation Biofeedback Therapy Device Revenue Market Share by Application (2021-2032)
6 Global Neurorehabilitation Biofeedback Therapy Device Sales by Region
  1. 6.1 Global Neurorehabilitation Biofeedback Therapy Device Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Neurorehabilitation Biofeedback Therapy Device Sales by Region (2021-2032)
  3. 6.2.1 Global Neurorehabilitation Biofeedback Therapy Device Sales by Region (2021-2026)
  4. 6.2.2 Global Neurorehabilitation Biofeedback Therapy Device Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Neurorehabilitation Biofeedback Therapy Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Neurorehabilitation Biofeedback Therapy Device Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Neurorehabilitation Biofeedback Therapy Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Neurorehabilitation Biofeedback Therapy Device Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Neurorehabilitation Biofeedback Therapy Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Neurorehabilitation Biofeedback Therapy Device Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Neurorehabilitation Biofeedback Therapy Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Neurorehabilitation Biofeedback Therapy Device Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Neurorehabilitation Biofeedback Therapy Device Revenue by Region
  1. 7.1 Global Neurorehabilitation Biofeedback Therapy Device Revenue by Region
  2. 7.1.1 Global Neurorehabilitation Biofeedback Therapy Device Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Neurorehabilitation Biofeedback Therapy Device Revenue by Region (2021-2026)
  4. 7.1.3 Global Neurorehabilitation Biofeedback Therapy Device Revenue by Region (2027-2032)
  5. 7.1.4 Global Neurorehabilitation Biofeedback Therapy Device Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Neurorehabilitation Biofeedback Therapy Device Revenue (2021-2032)
  8. 7.2.2 North America Neurorehabilitation Biofeedback Therapy Device Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Neurorehabilitation Biofeedback Therapy Device Revenue (2021-2032)
  11. 7.3.2 Europe Neurorehabilitation Biofeedback Therapy Device Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Neurorehabilitation Biofeedback Therapy Device Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Neurorehabilitation Biofeedback Therapy Device Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Neurorehabilitation Biofeedback Therapy Device Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Neurorehabilitation Biofeedback Therapy Device Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott
  2. 8.1.1 Abbott Company Information
  3. 8.1.2 Abbott Business Overview
  4. 8.1.3 Abbott Neurorehabilitation Biofeedback Therapy Device Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Neurorehabilitation Biofeedback Therapy Device Product Portfolio
  6. 8.1.5 Abbott Recent Developments
  7. 8.2 ARKRAY
  8. 8.2.1 ARKRAY Company Information
  9. 8.2.2 ARKRAY Business Overview
  10. 8.2.3 ARKRAY Neurorehabilitation Biofeedback Therapy Device Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 ARKRAY Neurorehabilitation Biofeedback Therapy Device Product Portfolio
  12. 8.2.5 ARKRAY Recent Developments
  13. 8.3 Ascensia
  14. 8.3.1 Ascensia Company Information
  15. 8.3.2 Ascensia Business Overview
  16. 8.3.3 Ascensia Neurorehabilitation Biofeedback Therapy Device Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Ascensia Neurorehabilitation Biofeedback Therapy Device Product Portfolio
  18. 8.3.5 Ascensia Recent Developments
  19. 8.4 B. Braun
  20. 8.4.1 B. Braun Company Information
  21. 8.4.2 B. Braun Business Overview
  22. 8.4.3 B. Braun Neurorehabilitation Biofeedback Therapy Device Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 B. Braun Neurorehabilitation Biofeedback Therapy Device Product Portfolio
  24. 8.4.5 B. Braun Recent Developments
  25. 8.5 BIONIME
  26. 8.5.1 BIONIME Company Information
  27. 8.5.2 BIONIME Business Overview
  28. 8.5.3 BIONIME Neurorehabilitation Biofeedback Therapy Device Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 BIONIME Neurorehabilitation Biofeedback Therapy Device Product Portfolio
  30. 8.5.5 BIONIME Recent Developments
  31. 8.6 GMMC Group
  32. 8.6.1 GMMC Group Company Information
  33. 8.6.2 GMMC Group Business Overview
  34. 8.6.3 GMMC Group Neurorehabilitation Biofeedback Therapy Device Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 GMMC Group Neurorehabilitation Biofeedback Therapy Device Product Portfolio
  36. 8.6.5 GMMC Group Recent Developments
  37. 8.7 LIANFA
  38. 8.7.1 LIANFA Company Information
  39. 8.7.2 LIANFA Business Overview
  40. 8.7.3 LIANFA Neurorehabilitation Biofeedback Therapy Device Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 LIANFA Neurorehabilitation Biofeedback Therapy Device Product Portfolio
  42. 8.7.5 LIANFA Recent Developments
  43. 8.8 Lifescan
  44. 8.8.1 Lifescan Company Information
  45. 8.8.2 Lifescan Business Overview
  46. 8.8.3 Lifescan Neurorehabilitation Biofeedback Therapy Device Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Lifescan Neurorehabilitation Biofeedback Therapy Device Product Portfolio
  48. 8.8.5 Lifescan Recent Developments
  49. 8.9 Lobeck Medical AG
  50. 8.9.1 Lobeck Medical AG Company Information
  51. 8.9.2 Lobeck Medical AG Business Overview
  52. 8.9.3 Lobeck Medical AG Neurorehabilitation Biofeedback Therapy Device Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Lobeck Medical AG Neurorehabilitation Biofeedback Therapy Device Product Portfolio
  54. 8.9.5 Lobeck Medical AG Recent Developments
  55. 8.10 Sinocare
  56. 8.10.1 Sinocare Company Information
  57. 8.10.2 Sinocare Business Overview
  58. 8.10.3 Sinocare Neurorehabilitation Biofeedback Therapy Device Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Sinocare Neurorehabilitation Biofeedback Therapy Device Product Portfolio
  60. 8.10.5 Sinocare Recent Developments
  61. 8.11 TERUMO
  62. 8.11.1 TERUMO Company Information
  63. 8.11.2 TERUMO Business Overview
  64. 8.11.3 TERUMO Neurorehabilitation Biofeedback Therapy Device Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 TERUMO Neurorehabilitation Biofeedback Therapy Device Product Portfolio
  66. 8.11.5 TERUMO Recent Developments
  67. 8.12 Roche
  68. 8.12.1 Roche Company Information
  69. 8.12.2 Roche Business Overview
  70. 8.12.3 Roche Neurorehabilitation Biofeedback Therapy Device Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Roche Neurorehabilitation Biofeedback Therapy Device Product Portfolio
  72. 8.12.5 Roche Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Neurorehabilitation Biofeedback Therapy Device Value Chain Analysis
  2. 9.1.1 Neurorehabilitation Biofeedback Therapy Device Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Neurorehabilitation Biofeedback Therapy Device Production Mode & Process
  6. 9.2 Neurorehabilitation Biofeedback Therapy Device Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Neurorehabilitation Biofeedback Therapy Device Distributors
  9. 9.2.3 Neurorehabilitation Biofeedback Therapy Device Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst